RUNX3 and acute promyelocytic leukemia: Together, the comparison of APL vs. AML2 revealed a diverse expression of well-known differentiation marker molecules, such as CD11b, CD13, CD14, CD15, and CD24, whereas fewer surface molecules were differentially expressed between APL and AML1.